>Correlia's Immunoassay Platform
Correlia's immunoassay tools reduce the time and cost for protein quantification. Their microscale technology enables measurements with broad dynamic range that are robust, automated, multiplexed, rapid, and require as little as 1 µL of starting sample when efficient protein quantitation is critical.
Fast assays complete as fast as 15min
Microscale: Data from as little as 1 uL of starting sample volume
Automated: Simple "walk-away, sample in/data out" operation, with minimal user intervention
Multiplexed: Up to 10 targets measured per sample
Broad Dynamic Range: up to 5 orders of magnitude
Within Correlia's consumable, target biomolecules are driven across a proprietary nanoporous substrate for highly efficient antigen-antibody binding.
mAb / Cytokine Response
Analyze Precious Samples：
They provide custom assay development and biosample testing services. Click here to know more.
Using a fraction of the sample, Correlia exceeds the detection range of gold-standard ELISA tests.
Correlia's first commercial instrument will be launched in 2021. Click here to request.
This web search service is supported by Google Inc.